Glycoengineering of plants yields glycoproteins with polysialylation and other defined N-glycoforms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 34, 2016, Pages 9404-9406

  Chen, Qiang ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN; NERVE CELL ADHESION MOLECULE; SIALIC ACID;

CONJUGATION; GLYCOENGINEERING; HUMAN; IMMUNOGENICITY; NONHUMAN; NOTE; PLANT CELL; PRIORITY JOURNAL; PROTEIN ENGINEERING; SIALYLATION; SYNTHESIS; TRANSGENIC PLANT; TRANSIENT EXPRESSION; GLYCOSYLATION; PLANT;

GLYCOPROTEINS; GLYCOSYLATION; PLANTS;

EID: 84983372172     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1610803113     Document Type: Note

References (15)

1. Loos A, Steinkellner H (2014) Plant glyco-biotechnology on the way to synthetic biology. Front Plant Sci 5:523.
2. Kallolimath S, et al. (July 21, 2016) Engineering of complex protein sialylation in plants. Proc Natl Acad Sci USA 113:9498-9503.
3. Varki A (2011) Evolutionary forces shaping the Golgi glycosylation machinery: Why cell surface glycans are universal to living cells. Cold Spring Harb Perspect Biol 3(6):a005462.
4. Yang Z, et al. (2015) Engineered CHO cells for production of diverse, homogeneous glycoproteins. Nat Biotechnol 33(8):842-844.
5. Chen Q, Davis KR (2016) The potential of plants as a system for the development and production of human biologics. F1000 Res 5(912):F1000 Faculty Rev-912.
6. Lai H, et al. (2014) Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnol J 12(8):1098-1107.
7. Zeitlin L, et al. (2011) Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc Natl Acad Sci USA 108(51):20690-20694.
8. Qiu X, et al. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514(7520):47-53.
9. Castilho A, et al. (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285(21):15923-15930.
10. Colley KJ, Kitajima K, Sato C (2014) Polysialic acid: Biosynthesis, novel functions and applications. Crit Rev Biochem Mol Biol 49(6):498-532.
11. Jain S, et al. (2003) Polysialylated insulin: Synthesis, characterization and biological activity in vivo. Biochim Biophys Acta 1622(1):42-49.
12. Constantinou A, et al. (2009) Site-specific polysialylation of an antitumor single-chain Fv fragment. Bioconjug Chem 20(5):924-931.
13. Dejnirattisai W, et al. (June 23, 2016) Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat Immunol, 10.1038/ni.3515.
14. He J, et al. (2014) Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus. PLoS ONE 9(3):e93541.
15. Hamilton SR, et al. (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313(5792):1441-1443.